Wirth Discusses SELECT Trial: Lenvatinib in RAI-Refractory DTC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Wirth Discusses SELECT Trial: Lenvatinib in RAI-Refractory DTC …
May 1, 2024
targetedonc.com
The Evolving Role of Lenvatinib in the HCC Therapeutic Landscape | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
The Evolving Role of Lenvatinib in the HCC Therapeutic Landscape | …
Apr 3, 2025
targetedonc.com
Gemcitabine-Oxaliplatin-Lenvatinib (GEMOX-LEN) For Unresectable Fibrolamellar Carcinoma: Promising Results in First 16 Patients
Gemcitabine-Oxaliplatin-Lenvatinib (GEMOX-LEN) For Unresectable Fi…
2 months ago
fibrofoundation.org
Dr. Feldman on Lenvatinib and Pembrolizumab Plus Chemotherapy in NSCLC | OncLive
Dr. Feldman on Lenvatinib and Pembrolizumab Plus Chemothera…
May 23, 2022
onclive.com
Dr. Martins on Managing Toxicities Associated With Lenvatinib in DTC | OncLive
Dr. Martins on Managing Toxicities Associated With Lenvatinib in DT…
Feb 25, 2016
onclive.com
Frontline Lenvatinib in HCC: Study 304 | OncLive
Frontline Lenvatinib in HCC: Study 304 | OncLive
Sep 8, 2017
onclive.com
Study Results: Lenvatinib in Renal Cell Carcinoma | OncLive
Study Results: Lenvatinib in Renal Cell Carcinoma | OncLive
Jan 29, 2016
onclive.com
Lenvatinib/Pembrolizumab in RCC: Dosing and Adverse Event Manag…
Apr 1, 2022
onclive.com
Dr. Cheng on Phase III Findings of Lenvatinib in HCC | OncLive
Jun 26, 2017
onclive.com
Managing Patients on Lenvatinib/Everolimus in mRCC | …
Jul 30, 2018
onclive.com
Lenvatinib Pembrolizumab as Frontline Therapy for Advanced R…
Mar 7, 2022
onclive.com
TACE Lenvatinib, Pembrolizumab Tied to Improved Survival in Unre…
267 viewsJan 15, 2025
diabetesincontrol.com
Lenvatinib in Metastatic Renal Cell Carcinoma | OncLive
Dec 19, 2015
onclive.com
Metastatic CRC: Pembrolizumab Plus Lenvatinib | OncLive
Aug 17, 2021
onclive.com
Dr. Finn on Considerations for Lenvatinib in Liver Cancer | OncLive
Sep 19, 2018
onclive.com
Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus P…
Sep 29, 2022
onclive.com
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadju…
2 months ago
targetedonc.com
3:52
LEAP Study: Lenvatinib Plus Pembrolizumab in Patients With R…
Mar 8, 2024
onclive.com
Approval of Lenvatinib: More Options | OncLive
Mar 4, 2015
onclive.com
EMERALD-3: tremelimumab durvalumab with or without lenvat…
Sep 10, 2022
vjoncology.com
Endometrial Cancer: Toxicity Management and Treatment Persi…
3 months ago
onclive.com
Next Steps With Pembrolizumab/Lenvatinib in End…
Apr 15, 2024
onclive.com
Dr. Cabanillas on Lenvatinib as First-Line Therapy for Patients Wi…
Feb 20, 2016
onclive.com
Impact of Lenvatinib-Pembrolizumab on Clinical Practic…
May 12, 2021
onclive.com
Lenvima (lenvatinib) mellékhatások, interakciók, felhasználások és gyó…
Aug 21, 2019
oldmedic.com
Dr. Armaghany on Frontline Sorafenib Versus Lenvatinib in Un…
Apr 4, 2020
onclive.com
4:27
Lenvatinib in Renal Cell Carcinoma
626 viewsFeb 24, 2016
YouTubeOncLive
KEYNOTE-775: Lenvatinib Plus Pembrolizumab in Advanced Endo…
Aug 3, 2023
onclive.com
0:05
Experiences and Thoughts on Lenvatinib for Cancer
7.8K views11 months ago
TikTokjasonkara
0:59
Dr. Martins on Managing Toxicities Associated With Lenvatinib in DTC
790 viewsFeb 25, 2016
YouTubeOncLive
See more videos
Static thumbnail place holder